145 related articles for article (PubMed ID: 21429630)
1. Synthesis of N-substituted 2-[(1E)-alkenyl]-4-(1H)-quinolone derivatives as antimycobacterial agents against non-tubercular mycobacteria.
Wube AA; Bucar F; Hochfellner C; Blunder M; Bauer R; Hüfner A
Eur J Med Chem; 2011 Jun; 46(6):2091-101. PubMed ID: 21429630
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and antimycobacterial activities of 1-methyl-2-alkenyl-4(1H)-quinolones.
Wube AA; Hüfner A; Thomaschitz C; Blunder M; Kollroser M; Bauer R; Bucar F
Bioorg Med Chem; 2011 Jan; 19(1):567-79. PubMed ID: 21106378
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antibacterial evaluation of a new series of N-Alkyl-2-alkynyl/(E)-alkenyl-4-(1H)-quinolones.
Wube A; Guzman JD; Hüfner A; Hochfellner C; Blunder M; Bauer R; Gibbons S; Bhakta S; Bucar F
Molecules; 2012 Jul; 17(7):8217-40. PubMed ID: 22777190
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of the quinolone antibacterials against mycobacteria: effect of structural changes at N-1 and C-7.
Renau TE; Sanchez JP; Gage JW; Dever JA; Shapiro MA; Gracheck SJ; Domagala JM
J Med Chem; 1996 Feb; 39(3):729-35. PubMed ID: 8576916
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antimycobacterial properties of ring-substituted 6-hydroxynaphthalene-2-carboxanilides.
Kos J; Nevin E; Soral M; Kushkevych I; Gonec T; Bobal P; Kollar P; Coffey A; O'Mahony J; Liptaj T; Kralova K; Jampilek J
Bioorg Med Chem; 2015 May; 23(9):2035-43. PubMed ID: 25819330
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and antimycobacterial activity evaluation of natural oridonin derivatives.
Xu S; Li D; Pei L; Yao H; Wang C; Cai H; Yao H; Wu X; Xu J
Bioorg Med Chem Lett; 2014 Jul; 24(13):2811-4. PubMed ID: 24835198
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and 2D QSAR study of novel pyridine and quinolone hydrazone derivatives as potential antimicrobial and antitubercular agents.
Abdelrahman MA; Salama I; Gomaa MS; Elaasser MM; Abdel-Aziz MM; Soliman DH
Eur J Med Chem; 2017 Sep; 138():698-714. PubMed ID: 28715707
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of novel N-acyl substituted quinolin-2(1H)-one derivatives as potential antimicrobial agents.
Liu HB; Tang H; Yang D; Deng Q; Yuan LJ; Ji QG
Bioorg Med Chem Lett; 2012 Sep; 22(18):5845-8. PubMed ID: 22902657
[TBL] [Abstract][Full Text] [Related]
9. Antimycobacterial and herbicidal activity of ring-substituted 1-hydroxynaphthalene-2-carboxanilides.
Gonec T; Kos J; Zadrazilova I; Pesko M; Keltosova S; Tengler J; Bobal P; Kollar P; Cizek A; Kralova K; Jampilek J
Bioorg Med Chem; 2013 Nov; 21(21):6531-41. PubMed ID: 24075143
[TBL] [Abstract][Full Text] [Related]
10. Antimycobacterial activities of 5-alkyl (or halo)-3'-substituted pyrimidine nucleoside analogs.
Srivastav NC; Shakya N; Bhavanam S; Agrawal A; Tse C; Desroches N; Kunimoto DY; Kumar R
Bioorg Med Chem Lett; 2012 Jan; 22(2):1091-4. PubMed ID: 22178557
[TBL] [Abstract][Full Text] [Related]
11. Quantitative structure-activity relationship (QSAR) studies of quinolone antibacterials against M. fortuitum and M. smegmatis using theoretical molecular descriptors.
Bagchi MC; Mills D; Basak SC
J Mol Model; 2007 Jan; 13(1):111-20. PubMed ID: 16932890
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anti-mycobacterial activities of triazoloquinolones.
Carta A; Palomba M; Briguglio I; Corona P; Piras S; Jabes D; Guglierame P; Molicotti P; Zanetti S
Eur J Med Chem; 2011 Jan; 46(1):320-6. PubMed ID: 21145625
[TBL] [Abstract][Full Text] [Related]
13. Primaquine hybrids as promising antimycobacterial and antimalarial agents.
Pavić K; Perković I; Pospíšilová Š; Machado M; Fontinha D; Prudêncio M; Jampilek J; Coffey A; Endersen L; Rimac H; Zorc B
Eur J Med Chem; 2018 Jan; 143():769-779. PubMed ID: 29220797
[TBL] [Abstract][Full Text] [Related]
14. Interaction of N-methyl-2-alkenyl-4-quinolones with ATP-dependent MurE ligase of Mycobacterium tuberculosis: antibacterial activity, molecular docking and inhibition kinetics.
Guzman JD; Wube A; Evangelopoulos D; Gupta A; Hüfner A; Basavannacharya C; Rahman MM; Thomaschitz C; Bauer R; McHugh TD; Nobeli I; Prieto JM; Gibbons S; Bucar F; Bhakta S
J Antimicrob Chemother; 2011 Aug; 66(8):1766-72. PubMed ID: 21622974
[TBL] [Abstract][Full Text] [Related]
15. Substituted xanthones as antimycobacterial agents, Part 2: Antimycobacterial activity.
Pickert M; Schaper KJ; Frahm AW
Arch Pharm (Weinheim); 1998 May; 331(5):193-7. PubMed ID: 9691249
[TBL] [Abstract][Full Text] [Related]
16. Lipophilic quinolone derivatives: Synthesis and in vitro antibacterial evaluation.
Sadowski E; Bercot B; Chauffour A; Gomez C; Varon E; Mainardis M; Sougakoff W; Mayer C; Sachon E; Anquetin G; Aubry A
Bioorg Med Chem Lett; 2022 Jan; 55():128450. PubMed ID: 34774742
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the antimycobacterial activity of 8-hydroxyquinolines.
Cieslik W; Spaczynska E; Malarz K; Tabak D; Nevin E; O'Mahony J; Coffey A; Mrozek-Wilczkiewicz A; Jampilek J; Musiol R
Med Chem; 2015; 11(8):771-9. PubMed ID: 26256587
[TBL] [Abstract][Full Text] [Related]
18. Purified compounds and extracts from Euclea species with antimycobacterial activity against Mycobacterium bovis and fast-growing mycobacteria.
McGaw LJ; Lall N; Hlokwe TM; Michel AL; Meyer JJ; Eloff JN
Biol Pharm Bull; 2008 Jul; 31(7):1429-33. PubMed ID: 18591787
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of alkynoic acids derivatives against mycobacteria.
Vilchèze C; Leung LW; Bittman R; Jacobs WR
Chem Phys Lipids; 2016 Jan; 194():125-38. PubMed ID: 26256431
[TBL] [Abstract][Full Text] [Related]
20. New benzimidazole derivatives as antimycobacterial agents.
Klimesová V; Kocí J; Waisser K; Kaustová J
Farmaco; 2002 Apr; 57(4):259-65. PubMed ID: 11989805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
